Clinical trial
Specific Clinical Experience Investigation of Nexium in Paediatric Patients
NCT03562026 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Specific Clinical Experience Investigation of Nexium in Paediatric Patients
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 28, 2018
- Completion date
- November 5, 2020
- Enrollment
- 240 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
peptic ulcer, gastroesophageal reflux